Eye-Light is the first known complete strategy for dry eye treatment. Intense pulsed light (IPL) technology alone has proven insufficient for meibomian gland dysfunction treatment, but through the powerful synergy between light modulation/ low-level light therapy (LLLT) and OPE/IPL technologies, Eye-Light now enables full dry eye treatment. Other related pathologies that can be successfully treated using Eye-Light include blepharitis, chalazion, demodex, dry eye caused by refractive and cataract surgery, post-blepharoplasty, and stye.
My Mask treatment option serves as an economical introduction, only involving gentle stimulation of the meibomian glands. Light modulation/ LLLT technology stimulates cell ATP production and endogenous heating of the upper and lower eyelids. Overall, LLLT results in a more stabilised tear lipid layer. You can always upgrade to Eye-Light.
Contact: Opticare (AUS) 02 9748 8777